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Abstract: 
Acanthamoebic keratitis is a distinct, vision-threatening ophthalmological condition, the 
incidence of which is increasing with increased usage of contact lenses. Diagnosis can 
be difficult and chemotherapeutic treatment is prolonged and often ineffective. 
It is therefore desirable to discover a quick and accurate means of diagnosing 
acanthamoebic keratitis, and to gain knowledge regarding which chemotherapeutic 
agents are most effective against acanthamoebic keratitis. 
The first goal of this thesis was to examine ten DNA extraction procedures and 
determine their effectiveness in extracting DNA from Acanthamoeba cells. 
Of these ten methods, four (2, 7, 8, 10) could be performed in less than one day and 
showed consistent results in PCR reactions. 
The second goal of this thesis involved the application of arbitrarily primed polymerase 
chain reaction (AP-PCR) in an attempt to type and group strains of Acanthamoeba 
species. 
Examination of 16 isolates with primers APOl, APO2, AMl, AM2, Pl and P2, showed 
each of the banding patterns, resulting from AP-PCR analysis, were unique to the isolate 
tested. Further, there were few bands which occurred in more than one isolate, with 
insufficient similarities to form groupings of isolates. 
Two chemotherapeutic agents were selected for a preliminary study into drug 
sensitivities in Acanthamoeba species and strains. 
The first of these was Baquacil (20% polyhexamethylene biguanide (PHMB)), and the 
second was Brolene (0.1 % propamidine isethionate). 
Within 48 hours 97% of all isolates tested reached zero viability at a concentration of 
0.05% PHMB, and 100% of isolates tested reached zero viability at 0.1 % PHMB. The 
results of this study would suggest that the concentration of PHMB be at least 0.05% 
when used to treat acanthamoebic keratitis . 
Within 48 hours of exposure to 0.1 % proparnidine isethionate (Brolene ), only 30% of all 
isolates tested reached zero viability. However, 60% of isolates tested showed at least 
80% reduction in viability within 48 hours of exposure to 0.1 % propamidine isethionate. 
The ultimate goal of this thesis was to form groups of isolates using PCR and drug 
sensitivities and to discover any correlation between these groups. The results of AP-
PCR analysis however suggests a high genetic heterogeneity within the Acanthamoeba 
genus, thus preventing any correlation with drug sensitivity tests. 
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CHAPTER ONE: Introduction 
1.1 PATHOGENIC FREE-LIVING AMOEBAE 
In the late nineteenth century amoebae were implicated in cases of dysentery and of 
organ and tissue abscesses (Wilhelmus, 1991 ). This was the first time amoebae were 
identified in human disease. These amoebae were parasitic, that is, needing a host to 
survive e.g. Entamoeba histolytica. Since then normally free-living (without need of a 
host) amoebae have also been recognised as opportunistic agents of human disease. 
Of all free-living amoebae only those of the genera Naegleria, Acanthamoeba and 
Balamuthia have been shown to cause disease in humans and other animals. (Visvesvara 
et al, 1993) 
These amoebae are able to live free in the environment, and as endoparasites. Normally 
they do not cause disease but live as phagotrophs, found in large numbers in soil, water 
and air, feeding on bacteria. (Anon., 1988 & John, 1993) As opportunists they may 
produce serious infection of the central nervous system (CNS) or the eye. (John, 1993) 
Naegleria fowleri, Balamuthia mandrillaris and several species of Acanthamoeba are 
able to cause an often fatal infection involving the CNS, amoebic meningoencephalitis . 
(Visvesvara et al, 1993) 
Additionally, some species of Acanthamoeba are able to produce a chronic, vision-
threatening infection of the cornea, known as acanthamoebic keratitis. (John, 1993) 
1.2 HISTORY OF ACANTHAMOEBA (John, 1993 & Wilhelmus, 1991) 
1930 
1957-58 
1958-59 
1971-73 
1974 
Castellani mentioned the presence of a special amoeba in cultures of 
Cryptococcus pararoseus and this was classified in the subgroup 
Hartmannella-Acanthamoeba.(John, 1993) · 
Two scientists, Culbertson and Jahnes, detected Acanthamoeba species 
as contaminants of tissue cultures causing cytopathic effects in Monkey 
kidney cell cultures. (John, 1993 & Wilhelmus, 1991) 
It was proposed that these amoebae have pathogenic potential. This was 
demonstrated when A culbertsoni was inoculated intracerebrally and 
intravenously into monkeys and mice causing meningoencephalitis. 
(John, 1993) 
The first clearly identified Acanthamoeba infections of the CNS in 
humans occurred. Prior to this date these amoebae were occasionally 
referred to as Hartmanella species, although it is now commonly 
accepted there are no (known) pathogenic Hartmannella species. 
(John, 1993) 
The first two cases of acanthamoebic keratitis were reported from Great 
Britain. (John, 1993) 
1975 
1980 
1983 
1985-95 
1996 
Amoebae cultured from both (above) British patients were 
identified as Acanthamoeba species. (John, 1993) 
The first United States cases of acanthamoebic keratitis were reported. 
(John, 1993) 
The term granulomatous amoebic encephalitis (GAE) was proposed to 
describe the CNS infection caused by Acanthamoeba species. (John, 
1993) 
Acanthamoeba species were isolated and cultured from human tissue 
samples for the first time. (John, 1993) 
Dramatic increase in numbers of acanthamoebic keratitis cases 
reported. This increase has been linked to the wearing of contact lenses, 
especially soft contact lenses. (John, 1993 & Wilhelmus, 1991) 
To date there have been six cases of acanthamoebic keratitis 
reported in New Zealand. (Cursons, pers comm.) 
1.3 BIOLOGY 
1.3.1 Morphology: 
2 
Acanthamoeba is found in two morphologically distinct forms; an environmentally 
resistant cyst and a feeding trophozoite or amoeba. It is the amoeba which is infective 
but both forms have been found in human tissue. (Anon, 1988 & John, 1993) 
The trophozoites are uninucleate, with characteristic fine cytoplasmic projections 
(acanthapodia) and the cysts are also uninucleate having a resistant stellate double wall. 
Both forms are resistant to most antimicrobial agents. (Anon, 1988) The nuclei of 
Acanthamoeba are characterised by having a large central nucleolus, or karyosome, and 
a nuclear membrane without chromatin granules. (John, 1993) 
1.3.1.a. Trophozoite: 
A distinguishing feature of the Acanthamoeba genera is the presence of acanthapodia, 
tapering spike-like pseudopodia. Acanthamoeba moves slowly on a broad front without 
direction and trophozoites average about 24-56µm in length. Nuclear division is 
metamitotic, where the nucleolus and the nuclear membrane disintegrate during early 
karyokinesis. (John, 1993) 
The cytoplasm consists of an amorphous hyaloplasm in the periphery emerging 
gradually with the granular endoplasm and its array of organella, mitochondria, 
ribosomes, phagocytic and pinocytic vacuoles, the pulsative complex, the centrosphere 
(essential for mitosis) and the nucleus. The numerous mitochondria usually have club-
like or ovoid shape. (Rondanelli and Scaglia, 1987) 
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1.3.1.b. Cyst: 
The cystic stage is preceded by several morphologic and functional changes among the 
cytoplasmic organella contained in the trophozoite. (Rondanelli and Scaglia, 1987) 
Considerable variation in cyst morphology occurs among the different species and this 
has been used in the naming of species. (John, 1993) 
Cysts are double walled and, therefore, quite resistant in the environment. The cyst wall 
is made up of an outer wrinkled, or rippled, ectocyst and an inner endocyst. (John, 1993) 
The two membranes appear separate along most of the cell perimeter and join only in 
areas corresponding to the tips of the polygonal limbs, where they form pores. A 
metacystic trophozoite is believed to break through these to leave the cyst. (Rondanelli 
and Scaglia, 1987) 
The karyosome in the cyst is smaller than that of the trophozoite and the granular 
cytoplasm contains many empty vacuoles and liquid droplets which, at times, line the 
whole inner surface of the cellular membrane. (Rondanelli and Scaglia, 1987) 
1.3.2 Life Cycle: 
Figure 1.3 .2: Life Cycle of Opportunistically Pathogenic Acanthamoeba Species. 
CYST 
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Invasion of the CNS appears to be by way of the circulation, with amoebae originating 
from a primary focus elsewhere in the body, possibly the respiratory tract, or ulcers of 
the skin or mucosa, or other wounds.(Ma et al, 1990 & John, 1993) 
GAE tends to occur in persons who are debilitated, chronically ill, or 
immunocompromised. In contrast acanthamoebic keratitis usually occurs in healthy 
individuals, and infection is by direct invasion of the cornea through trauma to the eye 
or the wearing of contaminated contact lenses.(John, 1993) 
1.4 CLASSIFICATION 
The genus Acanthamoeba was established in 1931. Since then Acanthamoeba. species 
have been variously referred to as Acanthamoeba, Hartmannella, and Mayorella. 
In 1930 Castellani discovered an amoeba in a culture of the fungus Cryptoccocus 
pararoseus. Douglas placed this amoeba in the genus Hartmanella that same year. 
Later, the genus Hartmanella was considered an artificial assemblage of unrelated 
amoebae and was subdivided into three genera, one of which was Acanthamoeba. 
These amoebae are characterised by the appearance of pointed spindles at mitosis and 
have double walled cysts with ostioles and an irregular outer layer. 
Between the years 1952 and 1979 there were continuing debates regarding the validity 
of the genus Acanthamoeba. These culminated in the acceptance of 17 species in the 
genus Acanthamoeba. Seven of these have been shown to be pathogenic to humans with 
a further three species pathogenic to mice. The currently accepted position of 
Acanthamoeba in the taxonomic scheme of the Society of Protozoologists is shown in 
Table 1.4.1 (Visvesvara, 1991 ). 
An additional classification system that is generally accepted ·is that of Pussard and Pons 
( 1977) which uses cyst morphology to divide the genus into three groups. 
Strains isolated from human infection fall into groups II and ill with the majority of 
corneal isolates falling into group IL 
Although the genus Acanthamoeba is easily recognised because of its distinctive 
acanthapodia and cyst structure, species identification is rather difficult. 
Traditional taxonomic criteria have been based on cyst morphology, nuclear divisions, 
temperature tolerance, and pathogenicity. The more recent approaches to Acanthamoeba 
classification have used isoenzyme analysis, restriction enzyme analysis of 
mitochondrial DNA and analysis of random fragment length polymorphism of total 
cellular DNA. (Cursons, 1978 & Ma ei al, 1990). However, the results of these analyses 
often have not correlated with species identification based on the more traditional 
criteria. 
In the end, the best classification scheme will be one that relies on many different 
characteristics, including morphological, physiological and biochemical ones. (John, 
1993) 
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Table 1.4.1: Currently Accepted Taxonomy (Visvesvara, 1991 & Ma et al, 1990) 
Kingdom: 
Subkingdom: 
Phylum: 
Subphylum: 
Superclass: 
Class: 
Subclass: 
Order: 
Suborder: 
Family: 
Genus: 
Protista 
Protozoa 
Sarcomastigophora 
Sarcodina 
Rh.izopodia (locomotion by lobopodia, filopodia, rectilopodia, 
or protoplasmic flow without production of 
discrete pseudopodia) 
Lobosea 
Gymnamoebia 
Amoebida (typically uninucleate; mitochondria present; no 
flagellate stage) 
Acanthopodina (more or less finely tipped, sometimes 
filiform, often furcate hyaline subpseudopodia 
produced from a broad hyaline lobe not 
regularly discoid; cyst usually formed; nuclear 
division mesomitotic or metamitotic) . 
Acanthamoebidae 
Acanthamoeba 
Species: Isolated from human infections at indicated site(s): 
A. astronyxis (CNS) 
A. castellani (CNS, eye) 
A. culbertsoni (CNS, eye) 
A. hatchetti (eye) 
A. palestinensis (CNS) 
A. polyphaga (CNS, eye) 
A. rysodes (CNS, eye} 
A. lugdunensis (eye) 
Not isolated from human infections: 
A. comandoni 
A. griffini 
A. lenticulata * 
A. royreba* 
A. tubiashi 
A. enchinulata 
A. divionensis 
A. triangularis 
A. mauritaniensis 
* shown to be pathogenic for mice 
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1.5 EPIDEMIOLOGY 
1.5.1 Occurrence/distribution of Acanthamoeba species: 
Acanthamoebae appear to be truly ubiquitous organisms with isolations recorded from: 
freshwater, bottled mineral water, frozen swimming water, distribution (i.e. tap) water, 
chlorinated swimming pools, physiotherapy pools and medicinal pools, hot tubs, 
brackish and sea water as well as ocean sediments, soil, compost, sewage, mushrooms 
and vegetables , dust in air, cooling towers of electric and nuclear power plants, heating, 
ventilating and air conditioning units, bacterial, fungal and mammalian cell cultures, 
fish, reptiles, birds, mammals (intestines, cerebral tissue, lung tissue, skin wounds, 
corneas) . In humans they have been found in the nose and throats of people with 
respiratory illness as well as from healthy persons, and in bronchial secretions, ear 
discharge, stool samples of patients with diarrhoea, intrauterine contraceptive devices, 
dialysis units, gastrointestinal washings, gastric-lavage tubing, dental units, contact 
lenses and contact lens solutions. (De Jonckheere et al, 1991 & Visvesvara et al, 1990) 
This apparently ubiquitous distribution is no doubt due to the possession of resistant 
cysts enabling these pathogenic free-living amoebae to withstand unfavourable 
conditions and to take advantage of the intermittent occurrence of favourable conditions. 
(Cursons, 1978) 
The distribution of pathogenic species to non-pathogenic ones is still unknown. In 
general pathogenic species are found in conditions where temperatures are above 
ambient, and closer to body temperature. (Cursons, 1978) 
1.5.2 Prevalence of disease caused by pathogenic free-living amoebae 
The following graph provides a comparison of the numbers of Primary Amoebic 
Meningitis, Granulomatous Amoebic Meningoencephalitis and acanthamoebic keratitis 
in several areas of the world (Visvesvara, pers comm.) . 
Figure 1.5.1 
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In most countries acanthamoebic keratitis is not a notifiable disease, therefore the true 
incidence is not known. A study in the USA revealed that where clinicians were familiar 
with acanthamoebic keratitis the numbers of cases reported were higher. 
The following graph compares reported numbers of acanthamoebic keratitis with those 
of GAE and PAM in the USA (Visvesvara and Stehr-Green, 1990). 
Figure 1.5.2 
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Figure 1.5.2 shows a dramatic increase in cases of acanthamoebic keratitis since 1980, 
while numbers of cases of PAM and GAE remain approximately static in occurrence. 
This increase correlates with increased usage of contact lenses. It has been suggested 
that contact lens use for purely cosmetic reasons is high in the United States of America. 
Therefore it would not be unreasonable to expect an increase in acanthamoebic keratitis 
in those areas of the world, shown in Figure 1.5.1, which currently have low contact lens 
usage, as contact lenses become more popular. It is also likely that although PAM and 
GAE appear to be of more importance in some areas, these diseases are not being 
reported at a higher frequency and acanthamoebic keratitis has the potential to overtake 
these statistics in a very short amount of time. 
For example, in New Zealand the majority of reported PAM cases occurred in a short 
period of time in the early 1970' s. Since that time perhaps 1 or 2 further cases have 
occurred. In comparison, 6 cases of acanthamoebic keratitis have been reported within 
the last 5 years (Cursons,pers comm.). 
1.6 DISEASES PRODUCED 
1.6.1 Granulomatous Amoebic Encephalitis (GAE): 
GAE usually occurs in debilitated or chronically ill, or immunocomprornised 
individuals, although some cases have been reported in otherwise healthy people. 
This disease is not well defined with the course of infection being subacute or chronic 
and lasting from weeks to months, or maybe even years. Onset is insidious with a 
prolonged clinical course during which single or multiple space-occupying focal 
granulomatous lesions develop in the brain. 
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An altered mental state is a prominent feature in GAE, with headache, seizures and neck 
stiffness occurring in about half of the cases. Nausea and vomiting may be present in 
some cases. 
Acanthamoeba infection probably occurs through the lower respiratory tract or through 
ulcers of the skin or mucosa. Invasion of the CNS occurs by haematogenous spread 
from the primary focus of infection. As the brain has no lymphatic channels the invasion 
must take place via the bloodstream. (John, 1993) 
1.6.2 Acanthamoebic keratitis: 
A chronic infection of the cornea caused by direct contact of the cornea with amoebae. 
This may occur through minor corneal trauma or exposure to contaminated water or 
contact lenses. (John, 1993) 
Acanthamoebic keratitis usually develops over a period of weeks to months. 
Characteristics of the disease include severe ocular pain, often out of proportion to the 
degree of inflammation, affected vision, and a paracentral corneal ring infiltrate. 
If not correctly treated this infection can lead to loss of vision and, in extreme cases, 
removal of the infected eye may be necessary. This disease on occasion is mistakenly 
diagnosed as Herpes simplex keratitis, with the only major difference in symptoms 
being the severity of ocular pain occurring in acanthamoebic infections.(John, 1993). 
This disease is further discussed later in this introduction. 
1. 7 IMMUNITY 
Because of the frequency and ease of isolation of pathogenic free-living amoebae 
(PFLA) from the environment, many authors have been puzzled regarding the low 
incidence of infection by PFLA in the human population. This has led many authors to 
speculate upon the existence of probable host-related susceptibility factors although 
these remain undefined. 
Antibodies to PFLA have been detected in normal human sera by indirect fluorescent-
antibody testing. These have been to both pathogenic and non-pathogenic free-living 
amoebae (Cursons et al., 1980 & John, 1993) 
Predisposition to infection by contact lens wearers may be because, 
1. the lens holds the amoebae in contact with the cornea, 
2. the lens causes minor trauma, allowing the amoebae to enter through the epithelfal 
layers, 
3. the lens protects the amoebae from removal by blinking or tear secretions, and/or 
4. levels of antibodies and complement are low in the eye. 
1.8 ACANTHAMOEBIC KERATITIS 
In 1973 Visvesvara reported the first case of acanthamoebic infection of the eye. 
(Asbell, 1993) Sporadic reports of ocular acanthamoebic infection followed; in 1982, 
not a single case of acanthamoebic keratitis was found in a 30-year review of 700 
patients with corneal ulcers, all of whom had undergone laboratory evaluation. (Asbell, 
1993) It was not until about 1985, after contact lens use, in particular soft and 
disposable (extended wear) contact lens use, had dramatically increased, that the 
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numbers of acanthamoebic keratitis cases being reported showed a marked increase and 
a direct association between contact lens wear and acanthamoebic keratitis was 
recognised. (Asbell, 1993) Between 1980 and 1985 there was a 59% increase in 
numbers of people wearing contact lenses in the United States of America. ( John, 1993) 
Acanthamoebic keratitis is a distinct, vision-threatening ophthalmological condition, 
causing serious concern in many countries. It is more common in economically 
developed countries where the wearing of contact lenses, for cosmetic and sight 
corrective purposes, is both fashionable and affordable. (John, 1993) 
Corneal trauma often precedes infection but this may not be a necessity. (Moore, 1990). 
Even minor trauma caused during the insertion, removal, or normal wearing of contact 
lenses can provide an avenue for entry of the micro-organisms. (Asbell, 1993) 
Because the clinical signs of acanthamoebic keratitis resemble herpetic, fungal or 
bacterial keratitis, diagnosis and treatment may be erroneous. (Home et al, 1994) 
1.8.1 Diagnosis: 
Common clinical signs of ocular acanthamoebic infection are breakdown of the corneal 
epithelium, the presence of satellite lesions, and iritis, sometimes with hypopyon. Often, 
after an initial period, the infection progresses slowly. Infection waxes and wanes, with 
corneal healing followed by recurrent epithelial deterioration. This can present a 
confusing picture to the clinician in practice. There may be elevated intraocular pressure 
and scleral inflammation. (Asbell, 1993) 
The primary sign of infection that has penetrated deep into the cornea is the combination 
of a central or paracentral ring infiltrate and remarkably intense pain. (Asbell, 1993) 
The initial method of diagnosis is to take corneal scrapings for culture on non-nutrient 
agar seeded with bacteria, and subsequent microscopic examination. It is often useful to 
examine contact lenses , storage cases and care solutions (where appropriate) as well as 
corneal tissue for the presence of acanthamoebic contamination. In some cases, biopsy 
may be necessary to obtain a firm diagnosis . (Home et al, 1994) 
It is important that specimens be examined by someone who is thoroughly familiar with 
the appearance of Acanthamoebae because these micro-organisms may be confused with 
degenerated epithelium or macrophages. (Anon., 1988) 
Species identification may be determined using a variety of staining techniques 
including indirect irnmunofluorescent antibody, Giemsa, and calcofluor white. 
Identification in histopathological specimens may be achieved by employing the 
haematoxylin and eosin procedure or a more specialised staining method e.g., 
Heidenhain's haematoxylin, Gomori's chromium haematoxylin, periodic acid-Schiff, 
Bauer chromic acid-Schiff and silver methanamine. (John, 1993) 
Herpes simplex keratitis is the most common misdiagnosis. The single most consistent 
clinical symptom is severe ocular pain, which is not characteristic of infection limited to 
the cornea and generally not present in Herpes simplex infection. Additional 
distinguishing features include a history of direct exposure to soil or water, wearing 
contact lenses, scleritis, and failure of cultures from the inflamed eye to reveal bacteria, 
fungi or viruses. (John, 1993) 
1.8.2 Pathology: 
The pathology of acanthamoebic keratitis is characterised by chronic progressive 
keratitis (John, 1993). In the early period of infection pseudodentritic figures in the 
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epithelium or just beneath the epithelium, in the anterior stroma, are typical pathological 
features. (John, 1993) 
This period is thus characterised by limbitis, perineural infiltrates and superficial 
epithelial changes, with few ring infiltrates and little anterior uveitis. (Bacon et al, 1993) 
As the infection progresses into the active period pathology includes frank ulceration, 
ring infiltrates and anterior uveitis often with hypopyon. Sometimes endothelial plaques 
causing corneal oedema occur. Perineural infiltrates are less common in early disease. 
(Bacon et al, 1993) In advanced cases there may be marked stromal infiltrate and 
necrosis. The whitish inflammatory infiltrate, often appearing ring-shaped around the 
corneal ulcer, consists mainly of polymorphonuclear leukocytes and macrophages with a 
few lymphocytes. (John, 1993) Evolution of severe features of the disease include ring 
ulcers, abscesses, scleritis, glaucoma, cataracts and secondary microbial infection. 
(Bacon et al, 1993). 
Although granulomatous inflammation has been described in acanthamoebic keratitis 
(John, 1993), in most of the reports, neutrophils, and not lymphocytes, are the 
predominant infiltrating cells. Corneal ulceration may progress to perforation (John, 
1993). Acanthamoebic ocular infections have been described variously as conjunctivitis, 
iritis, scleritis, and uveitis. (John, 1993). 
Acanthamoeba trophozoites and cysts occur within infected tissue. (John, 1993) 
1.8.3 Treatment: 
Initially most patients required surgical treatment, ranging from surgical debridement of 
the affected cornea to corneal transplantation or removal of the infected eyeball. (Asbell, 
1993 &John, 1993) 
The first successful chemotherapeutic treatment used a combination of 
dibromopropamidine and propamidine isethionate. Treatment was prolonged but 
curative. (Asbell, 1993) 
Current data suggest that cure is possible if acanthamoebic keratitis is diagnosed early, 
and appropriate medical treatment is initiated quickly and administered for a prolonged 
period i.e., six to twelve months.(Asbell, 1993) 
1.8.3.1 Pharmacology: 
The following drugs with varying efficacy have been used to treat cases of 
acanthamoebic keratitis. 
Topical propamidine, topical miconazole, systemic ketonazole, neosporin topical 
clotrimazole, oral itraconazole, neomycin., polyhexamethylene biguanide (PHMB), 
paromomycin, acriflavine, polymyxin B, colistin, crystal violet, methyl benzlkonium 
chloride, an experimental drug (Rl 1/29) and brilliant green. 
In some patients a combination of between three and twelve of these drugs were used, 
sometimes in combination with surgical debridement of lesions. (Asbell, 1993, John, 
1993, Bacon et al, 1993, Home et al, 1994) 
The most efficacious amoebistatic agents at present are pentamidine isethionate, 
propamidine isethionate, stilbamidine isethionate, clotrimazole and ketonazole. Ethanol 
and methanol have also showed activity against amoebae (Tomlinson, 1991). 
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Studies suggest that inhibitors of polyamine synthesis, e.g. diminazene aceturate, 
pentamidine and methylglyoxal bis(guanylhydrazone)(mitoguazone) could be developed 
to aid in chemotherapy for acanthamoebic infections. (Shukla, 1991) 
Magainins from the skin of a south African toad were shown to be inhibitory to 
trophozoite growth and, although not cysticidal, may be useful in the management of 
acanthamoebic keratitis. (Feldman et al, 1991) 
Local corticosteroids may be detrimental to the host in the presence of acanthamoebic 
keratitis. These were commonly used in early cases where prognosis was likely 
keratoplasty in order to limit inflammation and increase successful surgery. (John et al, 
1991b) 
1.8.4 Risk factors: 
Risk factors involved in contraction of acanthamoebic keratitis include wearing contact 
lenses, use of nonpreserved ophthalmologic products (e.g., home-made saline), exposure 
of eyes to nonsterile water sources (e.g., well, tap, sea and surface water), contamination 
of contact-lens storage cases and of storage and rinsing solutions, trauma to the eye, 
compromised host defence mechanisms and corneal surgery. (Home et al, 1994) 
Eighty percent of reported cases of acanthamoebic keratitis have occurred among 
contact lens wearers, 75% of whom wore daily-wear or extended-wear soft hydrogel 
lenses. 
There is also evidence to suggest that a great many lens wearers remove lenses, usually 
because of dust, dirt or ocular irritation, and reinsert them later after a rinse in tap water 
or saline, without disinfection. (Asbell, 1993) 
The risk factors associated with contact lens wear include: 
Lens materials. All modem contact lenses contain a certain amount of water which 
serves as a medium for oxygen influx. In proportion to their water content, lenses absorb 
material, including potential pathogens, from cleaning solutions, lens cases, and patients 
hands. Thus, lens material itself can be a risk factor for acanthamoebic infection. 
(Asbell, 1993) 
Lens Cleaning and Disinfection. Preservatives in solutions were major culprits in 
discomfort. This led practitioners to recommend the use of unpreserved, home-made, 
solutions. At this time it was not known that Acanthamoeba was ubiquitous in the 
environment, and particularly in tapwater. The marked increase in acanthamoebic 
infections during the 1980s certainly reflected, to a degree, widespread use of non-
sterile, unpreserved solutions. This practice is now actively discouraged. (Asbell, 1993) 
Other sources of lens contamination result from the patient not following disinfection 
regimes properly or rinsing lenses in tap water to remove disinfecting solution or dust 
particles. (Asbell, 1993) 
Lens Storage Cases. In studies involving 102 asymptomatic lens wearers and their lens 
cases it was discovered that about half of the lens cases contained significant amounts of 
bacteria and seven cases contained Acanthamoeba. In general Acanthamoeba do not 
occur alone and it is possible a synergistic or symbiotic relationship with other bacteria 
allows Acanthamoeba to grow to levels where there becomes a significant risk of 
pathogenic infection. 
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At the moment there is no obvious solution to this problem (Asbell, 1993), although one 
suggestion is that the contact lens case be replaced with the purchase of disinfection 
systems. 
Extended Wear. A study in 1989 showed that soft-lens wearers who slept with lenses in 
were 10-15 times more likely to develop ulcerative keratitis than those who wore lenses 
only during waking hours. (Asbell, 1993) 
Lens Degradation. Contact lenses, over a period of time, eventually develop deposits. 
This is unavoidable and are in fact part of a biofilm. This biofilm is produced in 
response to a foreign body (the lens) enabling the body to recognise the lens and not 
react adversely to them. However it is also a source of contamination, adding to the risk 
of infection. (Asbell, 1993) 
1.9 SUMMARY AND GOALS 
There are few free-living amoebae that are also opportunistic agents of human disease. 
One genera of amoebae that is capable of this is Acanthamoeba. 
Some strains of Acanthamoeba are able to produce one or both of two distinct disease 
states in humans. The first of these is Granulomatous Amoebic Encephalitis (GAE), an 
infection of the central nervous system that can be compared to amoebic meningitis ( or 
primary amoebic meningoencephalitis - PAM). PAM is caused by another pathogenic 
free-living amoeba, Naegleriafowleri. 
The second disease state caused by Acanthamoebae is a chronic infection of the cornea 
known as acanthamoebic keratitis. 
All diseases caused by pathogenic free-living amoebae occur infrequently, however the 
incidence of acanthamoebic keratitis is increasing. This in~rease has been linked with 
the increased usage of contact lenses, and in particular, soft contact lenses. Once 
diagnosed, chemotherapeutic treatment is prolonged and often ineffective. This can 
render necessary surgical means of controlling the disease. Surgical options include 
debridement of lesions, keratoplasty or, in extreme cases, removal of the infected 
eyeball. 
It is therefore desirable to discover a quick and accurate means of diagnosing 
acanthamoebic keratitis, and to gain knowledge regarding which chemotherapeutic 
agents are most effective against acanthamoebic keratitis. 
The goals of this thesis are: 
1. To compare methods of extracting DNA from Acanthamoeba species in order to 
2. Evaluate the polymerase chain reaction as a means of diagnosis of acanthamoebic 
keratitis and differentiation of Acanthamoeba species and strains. 
3. To conduct preliminary in vitro drug sensitivity trials. 
4. To determine whether any correlation exists between drug sensitivities and 
banding patterns revealed by PCR. 
